Quince Therapeutics, Inc. Skyrocketed
Wed, Nov 26, 2025 at 07:46 PM
Quince Therapeutics, Inc. (QNCX:NASDAQ) rocketted at $3.45, representing a gain of 29.2%. On Wed, Nov 26, 2025, QNCX:NASDAQ touched a New 2-Week High of $3.45. The stock appeared on our News Catalysts scanner on Mon, Nov 24, 2025 at 10:07 AM in the 'MISCELLANEOUS' category. From Thu, Nov 13, 2025, the stock recorded 88.89% Up Days and 80.00% Green Days
About Quince Therapeutics, Inc. (QNCX:NASDAQ)
Cortexyme Inc is a clinical-stage biopharmaceutical company developing a disease-modifying therapeutic approach to treat Alzheimer's and other degenerative diseases.
Top 10 Gainers:
- SMX (Security Matters) Public Limited Company (SMX:NASDAQ), 194.42%
- Pasithea Therapeutics Corp. (KTTA:NASDAQ), 117.39%
- Amber International Holding Limited (AMBR:NASDAQ), 56.33%
- KALA BIO, Inc. (KALA:NASDAQ), 42.63%
- Quantum BioPharma Ltd. (QNTM:NASDAQ), 41.92%
- Mobile-health Network Solutions (MNDR:NASDAQ), 39.47%
- Verrica Pharmaceuticals Inc. (VRCA:NASDAQ), 31.05%
- K Wave Media Ltd. (KWM:NASDAQ), 29.59%
- Boqii Holding Limited (BQ:NYSEMKT), 29.55%
- Quince Therapeutics, Inc. (QNCX:NASDAQ), 29.21%